Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 13, 2020 21:05 UTC |
Anchin Scott LDirector
|
GrantStock Option (right to buy) · Derivative | 20,786 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001104659-20-003447 · tm203236d1_form4.xml · derivative · entry 2 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,786 Underlying: Common Stock · 20,786 shares Expires 2030-01-02 F2 · derivative.exercise_date: 9,121 of these options vest and become exercisable on the six-month anniversary of the date of grant subject to continuation of the consulting agreement through such date. The remaining 11,665 of these options vest on 12/12/2020 subject to the continuation of the consulting agreement through that date. Read SEC document |
| December 12, 2019 Filed Dec 12, 2019 17:40 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 22,000 | $1.21 Strike: $5.25 | $26,699.20 |
DisclosureSEC source: 0001763113-19-000012 · primary_doc.xml · derivative · entry 3 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Applied DNA Sciences Inc. 5 year warrant · 22,000 shares Expires 2024-11-15 F1 · balance_after: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 6.48%. If I exercised all of my warrants that are able to be exercised under the terms of these warrants my ownership would be 9.99%. Read SEC document |
| December 12, 2019 Filed Jan 13, 2020 21:05 UTC |
Anchin Scott LDirector
|
GrantStock Option (right to buy) · Derivative | 20,834 | $0.00 Strike: $4.26 | $0.00 |
DisclosureSEC source: 0001104659-20-003447 · tm203236d1_form4.xml · derivative · entry 1 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,834 Underlying: Common Stock · 20,834 shares Expires 2029-12-12 F1 · derivative.exercise_date: These options vest in full and become exercisable on June 12, 2020 subject to continuation of the consulting agreement through such date. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 17:40 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 1,000 | $1.20 Strike: $5.25 | $1,200.00 |
DisclosureSEC source: 0001763113-19-000012 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,000 Underlying: Applied DNA Sciences Inc. Common Stock · 1,000 shares Expires 2024-11-15 Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 17:40 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001763113-19-000012 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,774 Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 20:29 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 2,000 | $0.96 Strike: $5.25 | $1,920.00 |
DisclosureSEC source: 0001763113-19-000011 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,000 Underlying: Applied DNA Sciences Inc. Common Stock · 2,000 shares Expires 2024-11-15 F1 · balance_after: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 6.48%. If I exercised all of my warrants that are able to be exercised under the terms of these warrants my ownership would be 9.99% Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 20:29 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001763113-19-000011 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,774 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:52 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 65,000 | $1.19 Strike: $5.25 | $77,389.00 |
DisclosureSEC source: 0001763113-19-000010 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Applied DNA Sciences Inc. Common Stock · 65,000 shares Expires 2024-11-15 F1 · balance_after: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 6.48%. If I exercised all of my warrants that are able to be exercised under the terms of these warrants my ownership would be 9.99%. F1 · ownership.direct: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 6.48%. If I exercised all of my warrants that are able to be exercised under the terms of these warrants my ownership would be 9.99%. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:52 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001763113-19-000010 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,774 Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 19:59 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 10,000 | $0.99 Strike: $5.25 | $9,910.00 |
DisclosureSEC source: 0001763113-19-000009 · primary_doc.xml · derivative · entry 3 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Applied DNA Sciences Inc. Common Stock · 10,000 shares Expires 2024-11-15 F1 · balance_after: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 6.48%. If I exercised all my warrants (and no others did so) my ownership would be 9.97%. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 19:59 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001763113-19-000009 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,774 Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 19:59 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 50,000 | $0.90 Strike: $5.25 | $45,000.00 |
DisclosureSEC source: 0001763113-19-000009 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Applied DNA Sciences Inc. Common Stock · 50,000 shares Expires 2024-11-15 Read SEC document |
| November 13, 2019 Filed Nov 13, 2019 23:46 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 75,000 | $0.01 Strike: $5.25 | $750.00 |
DisclosureSEC source: 0001763113-19-000008 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Applied DNA Sciences, Inc. Common Stock · 75,000 shares Expires 2024-11-15 Read SEC document |
| November 13, 2019 Filed Nov 13, 2019 23:46 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 75,000 | $5.24 | $393,000.00 |
DisclosureSEC source: 0001763113-19-000008 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,774 F1 · shares: Shares purchased in $12 million underwritten public offering by Maxim Group LLC F2 · balance_after: Previously reported 6,030.900 shares reduced to 150,774 shares in 1 for 40 reverse split on 11/1/19 F3 · balance_after: With the increase in APDN common shares outstanding from the $12 million public underwritten offering on 11/13/19, my percentage ownership is now below the 10% ownership level but still above the 5% ownership level requiring SEC reporting Read SEC document |
| September 24, 2019 Filed Sep 25, 2019 20:02 UTC |
Bitzer John IIIDirector
|
OtherSecured Convertible Note · Derivative | 106,197 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-045919 · tv530050_form4.xml · derivative · entry 2 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 196,661 shares Expires 2021-11-28 F2 · ownership.nature: The shares are owned by Delabarta II, Inc. Mr. Bitzer is president of Delabarta II, Inc. Read SEC document |
| September 24, 2019 Filed Sep 25, 2019 20:02 UTC |
Bitzer John IIIDirector
|
OtherCommon Stock | 196,661 | $0.54 | $106,196.94 |
DisclosureSEC source: 0001144204-19-045919 · tv530050_form4.xml · nonDerivative · entry 1 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,409,383 F1 · shares: The shares were issued as a result of the conversion of $106,197 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. F2 · ownership.nature: The shares are owned by Delabarta II, Inc. Mr. Bitzer is president of Delabarta II, Inc. Read SEC document |
| September 16, 2019 Filed Sep 16, 2019 20:58 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences, Inc. Common Stock | 6,678 | $0.36 | $2,390.06 |
DisclosureSEC source: 0001763113-19-000007 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,030,900 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:01 UTC |
Schmalz Elizabeth MDirector
|
OtherSecured Convertible Note · Derivative | 10,620 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-044889 · tv529554_4.xml · derivative · entry 2 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,666 shares Expires 2021-11-28 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:01 UTC |
Schmalz Elizabeth MDirector
|
OtherCommon Stock | 19,666 | $0.54 | $10,619.64 |
DisclosureSEC source: 0001144204-19-044889 · tv529554_4.xml · nonDerivative · entry 1 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,030 F1 · shares: The shares were issued as a result of the conversion of $10,620 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:58 UTC |
Montgomery William W10% owner
|
OtherApplied DNA Sciences Inc. Common Stock | 393,322 | $0.54 | $212,393.88 |
DisclosureSEC source: 0001763113-19-000007 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,024,222 F1 · shares: 1. The shares were issued as a result of the conversion of $212,394 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:03 UTC |
Murrah JudithChief Information Officer
|
OtherSecured Convertible Note · Derivative | 26,549 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-044708 · tv529472_4.xml · derivative · entry 2 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,165 shares Expires 2021-11-28 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:03 UTC |
Murrah JudithChief Information Officer
|
OtherCommon Stock | 49,165 | $0.54 | $26,549.10 |
DisclosureSEC source: 0001144204-19-044708 · tv529472_4.xml · nonDerivative · entry 1 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,863 F1 · shares: The shares were issued as a result of the conversion of $26,549 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:02 UTC |
CATELL ROBERT BDirector
|
OtherSecured Convertible Note · Derivative | 26,549 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-044707 · tv529471_4.xml · derivative · entry 2 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,165 shares Expires 2021-11-28 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:02 UTC |
CATELL ROBERT BDirector
|
OtherCommon Stock | 49,165 | $0.54 | $26,549.10 |
DisclosureSEC source: 0001144204-19-044707 · tv529471_4.xml · nonDerivative · entry 1 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,575 F1 · shares: The shares were issued as a result of the conversion of $26,549 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:01 UTC |
Hayward James ADirector · Chief Executive Officer · 10% owner
|
OtherSecured Convertible Note · Derivative | 1,585,313 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-044703 · tv529469_4.xml · derivative · entry 2 Hayward James A · CIK 0001357784 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,935,764 shares Expires 2021-11-28 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:01 UTC |
Hayward James ADirector · Chief Executive Officer · 10% owner
|
OtherCommon Stock | 2,935,764 | $0.54 | $1,585,312.56 |
DisclosureSEC source: 0001144204-19-044703 · tv529469_4.xml · nonDerivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367,435 F1 · shares: The shares were issued as a result of the conversion of $1,585,313 of secured convertible notes that were originally issued on August 31, 2019 and November 30, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:02 UTC |
SHAMASH YACOV ADirector
|
OtherSecured Convertible Note · Derivative | 26,549 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001144204-19-044705 · tv529470_4.xml · derivative · entry 2 SHAMASH YACOV A · CIK 0001013589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,165 shares Expires 2021-11-28 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:02 UTC |
SHAMASH YACOV ADirector
|
OtherCommon Stock | 49,165 | $0.54 | $26,549.10 |
DisclosureSEC source: 0001144204-19-044705 · tv529470_4.xml · nonDerivative · entry 1 SHAMASH YACOV A · CIK 0001013589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,370 F1 · shares: The shares were issued as a result of the conversion of $26,549 of secured convertible notes that were originally issued on August 31, 2019 and represent the outstanding principal and interest of such secured convertible notes. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 21:09 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 400,000 | $0.27 | $108,000.00 |
DisclosureSEC source: 0001763113-19-000006 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,630,900 Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:17 UTC |
Murrah JudithChief Information Officer
|
GrantCommon Stock | 37,038 | $0.27 | $10,000.26 |
DisclosureSEC source: 0001144204-19-041670 · tv528205_form4.xml · nonDerivative · entry 1 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,698 Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:17 UTC |
Hayward James ADirector · Chairman, CEO, and President · 10% owner
|
GrantCommon Stock | 370,371 | $0.27 | $100,000.17 |
DisclosureSEC source: 0001144204-19-041671 · tv528206_form4.xml · nonDerivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chairman, CEO, and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,431,671 Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:02 UTC |
CATELL ROBERT BDirector
|
GrantStock Option (right to buy) · Derivative | 198,826 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027500 · tv522082_4.xml · derivative · entry 1 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,826 Underlying: Common Stock · 198,826 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:13 UTC |
Simon Sanford RDirector
|
GrantStock Option (right to buy) · Derivative | 198,826 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027509 · tv522088_4.xml · derivative · entry 1 Simon Sanford R · CIK 0001357785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,826 Underlying: Common Stock · 198,826 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:11 UTC |
SHAMASH YACOV ADirector
|
GrantStock Option (right to buy) · Derivative | 198,826 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027508 · tv522087_4.xml · derivative · entry 1 SHAMASH YACOV A · CIK 0001013589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,826 Underlying: Common Stock · 198,826 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:09 UTC |
Ryan Charles S.Director
|
GrantStock Option (right to buy) · Derivative | 175,435 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027507 · tv522085_4.xml · derivative · entry 1 Ryan Charles S. · CIK 0001624830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,435 Underlying: Common Stock · 175,435 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:08 UTC |
Schmalz Elizabeth MDirector
|
GrantStock Option (right to buy) · Derivative | 198,826 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027505 · tv522084_4.xml · derivative · entry 1 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,826 Underlying: Common Stock · 198,826 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:06 UTC |
Ceccoli Joseph D.Director
|
GrantStock Option (right to buy) · Derivative | 198,826 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027503 · tv522083_4.xml · derivative · entry 1 Ceccoli Joseph D. · CIK 0001627545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,826 Underlying: Common Stock · 198,826 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:01 UTC |
Bitzer John IIIDirector
|
GrantStock Option (right to buy) · Derivative | 175,435 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027497 · tv522081_4.xml · derivative · entry 1 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,435 Underlying: Common Stock · 175,435 shares Expires 2029-05-16 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| January 24, 2019 Filed Jan 24, 2019 15:21 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 50,000 | $0.47 | $23,745.00 |
DisclosureSEC source: 0001763113-19-000004 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,230,900 Read SEC document |
| January 23, 2019 Filed Jan 24, 2019 15:21 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 90,000 | $0.46 | $41,499.00 |
DisclosureSEC source: 0001763113-19-000004 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,180,900 Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 22:02 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 60,000 | $0.44 | $26,610.00 |
DisclosureSEC source: 0001763113-19-000003 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090,900 Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 22:02 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 100,000 | $0.44 | $44,480.00 |
DisclosureSEC source: 0001763113-19-000003 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030,900 Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 17:21 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 216,000 | $0.47 | $100,591.20 |
DisclosureSEC source: 0001763113-19-000002 · primary_doc.xml · nonDerivative · entry 3 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,930,900 Read SEC document |
| January 03, 2019 Filed Jan 8, 2019 17:21 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 154,000 | $0.44 | $67,051.60 |
DisclosureSEC source: 0001763113-19-000002 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,714,900 Read SEC document |
| December 31, 2018 Filed Jan 8, 2019 17:21 UTC |
Montgomery William W10% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 30,000 | $0.37 | $11,139.00 |
DisclosureSEC source: 0001763113-19-000002 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,560,900 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:05 UTC |
Jantzen BethChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001144204-18-064272 · tv508911_4.xml · derivative · entry 2 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 4,167 shares Expires 2023-12-09 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:05 UTC |
Jantzen BethChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001144204-18-064272 · tv508911_4.xml · derivative · entry 1 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2018-12-10 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. F1 · derivative.expiration_date: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:04 UTC |
Murrah JudithChief Information Officer
|
GrantStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001144204-18-064271 · tv508910_4.xml · derivative · entry 2 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 4,167 shares Expires 2023-12-09 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:04 UTC |
Murrah JudithChief Information Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001144204-18-064271 · tv508910_4.xml · derivative · entry 1 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2018-12-10 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. F1 · derivative.expiration_date: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting. Read SEC document |
| December 02, 2018 Filed Dec 3, 2018 21:02 UTC |
Murrah JudithChief Information Officer
|
GrantStock Option (right to buy) · Derivative | 33,334 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001144204-18-062853 · tv508166_4.xml · derivative · entry 2 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 33,334 shares Expires 2023-12-01 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 2, 2018 to December 1, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 2, 2013 and provided for vesting (i) with respect to 25% of the underlying shares on the anniversary of the original grant date and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the fourth anniversary of the original date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.